March 6, 2018 / 1:13 AM / 9 months ago

Professors urge Federal Circuit to revive Cleveland Clinic biotech patents

A group of six patent law professors last week urged a federal appeals court to recognize the validity of diagnostic testing patents owned by the Cleveland Clinic, saying lower courts are improperly canceling biotech patents based on a misunderstanding of what constitutes eligible subject matter.

The scholars told the U.S. Federal Circuit Court of Appeals in a Feb. 28 amicus brief that a federal judge erred in ruling invalid patents on a method of detecting cardiovascular disease the Cleveland Clinic had accused healthcare company True Health Group LLC of infringing.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below